MXPA04011768A - Mejoras relativas a funciones inmunes. - Google Patents

Mejoras relativas a funciones inmunes.

Info

Publication number
MXPA04011768A
MXPA04011768A MXPA04011768A MXPA04011768A MXPA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A
Authority
MX
Mexico
Prior art keywords
unit dose
liquid form
phosphotidyl
resveratrol
psk
Prior art date
Application number
MXPA04011768A
Other languages
English (en)
Spanish (es)
Inventor
Donald Farley Michael
Original Assignee
Donald Farley Michael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donald Farley Michael filed Critical Donald Farley Michael
Publication of MXPA04011768A publication Critical patent/MXPA04011768A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MXPA04011768A 2003-01-09 2003-01-09 Mejoras relativas a funciones inmunes. MXPA04011768A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/000709 WO2004062683A1 (en) 2003-01-09 2003-01-09 Improvements in or relating to immune functions

Publications (1)

Publication Number Publication Date
MXPA04011768A true MXPA04011768A (es) 2005-03-31

Family

ID=34885486

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04011768A MXPA04011768A (es) 2003-01-09 2003-01-09 Mejoras relativas a funciones inmunes.

Country Status (7)

Country Link
EP (1) EP1581238B1 (https=)
JP (1) JP2006501308A (https=)
CN (1) CN100579535C (https=)
AT (1) ATE395925T1 (https=)
DE (1) DE60321227D1 (https=)
MX (1) MXPA04011768A (https=)
WO (1) WO2004062683A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697670B2 (en) * 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
ES2428665B1 (es) * 2012-05-04 2014-10-01 Universidad De Valladolid Composición para su uso en el tratamiento y/o prevención de la inflamación, el estrés oxidativo y la neovascularización ocular
CN106974904B (zh) * 2017-03-14 2020-07-28 南方医科大学 杨梅素及其衍生物的新用途和一种抗hiv感染的杀微生物剂
CN110772578A (zh) * 2019-11-11 2020-02-11 李胜 一种用于癌症防治的人体免疫力增强剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175985A1 (en) * 1995-05-10 1996-11-11 Yoichi Kiyosuke Pharmaceutical composition containing substance inhibiting hsp47 production
US6238673B1 (en) * 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions
TR199900610T2 (xx) * 1996-09-20 1999-06-21 The Howard Foundation Polifenol i�eren terkiplerin �retim y�ntemi.
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US20020192310A1 (en) * 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance

Also Published As

Publication number Publication date
CN100579535C (zh) 2010-01-13
WO2004062683A1 (en) 2004-07-29
DE60321227D1 (de) 2008-07-03
CN1638786A (zh) 2005-07-13
JP2006501308A (ja) 2006-01-12
EP1581238B1 (en) 2008-05-21
HK1078471A1 (zh) 2006-03-17
ATE395925T1 (de) 2008-06-15
EP1581238A1 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
US6544564B1 (en) Cytotoxic pharmaceutical composition
Park et al. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines
US20090047371A1 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
US20030082203A1 (en) Immune functions
Chen et al. Methylwogonin exerts anticancer effects in A375 human malignant melanoma cells through apoptosis induction, DNA damage, cell invasion inhibition and downregulation of the mTOR/PI3K/Akt signalling pathway
MXPA04011768A (es) Mejoras relativas a funciones inmunes.
Ghate et al. Polyphenols, spices and vegetarian diet for immunity and anti-inflammatory drug design
Grover et al. Curcumin: A medicinal plant and its effects in medicine and dentistry
Gupta Synergistic anti-cancer effects of natural products and their mode of action
Tai et al. Aqueous Extract of Solanum nigrum Leaf Activates Autophagic Cell Death and Enhances Docetaxel‐Induced Cytotoxicity in Human Endometrial Carcinoma Cells
CO6241128A2 (es) Compuestos extraidos de residuos de molienda de aceite de palma para el tratamiento del cancer composiciones de los mismos y metodos acompañantes
Alavi Dana et al. Anti-cancer potential of Hypericum spp. With focus on Hypericum perforatum: A review of the literature
US20180235904A1 (en) Cannabidiol compositions including mixtures and uses thereof
CN113038962A (zh) 印楝组合物和治疗癌症的方法
Koriem Cortex Uncariae: A review on pharmacology, toxicology, precautions, and dosage
Wimardhani et al. Oral mucosal ulceration caused by the topical application of a concentrated propolis extract
Sekhar et al. A review on anticancer potential of natural drugs: hispolon and limonene
JP2014224083A (ja) 性機能増強組成物
HK1078471B (en) Improvements in or relating to immune functions
MX2022007304A (es) Uso de lemborexant para tratamiento del insomnio.
Bawa et al. Clinical Uses of Piperine: A Review
S. Kataki et al. Women’s Ginseng (Angelica sinensis): an ethnopharmacological dossier
Ramkumar et al. In-vitro Anti-Cancer and Anti-Inflammatory Screening of Dodonaea viscosa
Moafa Formulation, optimization and evaluation of piperine loaded nanovesicles medicated drug delivery for the treatment of cancer
Alhawiti Cytotoxicity, Toxicity and Anticancer Activity of Manuka Honey, Saudi's Honey and Peganum harmala Plant Against Cancer Cells

Legal Events

Date Code Title Description
FG Grant or registration